Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Dis Colon Rectum. 2013 Jul;56(7):834-43. doi: 10.1097/DCR.0b013e318294ed6b.
Bowel obstruction is a common complication of late-stage abdominal cancer, especially colon cancer, which has been investigated predominantly in small, single-institution studies.
We used a large, population-based data set to explore the surgical treatment of bowel obstruction and its outcomes after hospitalization for obstruction among patients with stage IV colon cancer.
This was a retrospective cohort study.
We identified 1004 patients aged 65 years or older in the Surveillance, Epidemiology and End Results-Medicare database diagnosed with stage IV colon cancer January 1, 1991 to December 31, 2005, who were later hospitalized for bowel obstruction.
We describe outcomes after hospitalization and analyzed the associations between surgical treatment of obstruction and outcomes.
Hospitalization for bowel obstruction occurred a median of 7.4 months after colon cancer diagnosis, and median survival after obstruction was approximately 2.5 months. Median hospitalization for obstruction was about 1 week and in-hospital mortality was 12.7%. Between discharge and death, 25% of patients were readmitted to the hospital at least once for obstruction, and, on average, patients lived 5 days out of the hospital for every day in the hospital between obstruction diagnosis and death. Survival was 3 times longer in those whose obstruction claims suggested an adhesive obstruction origin. In multivariable models, surgical compared with nonsurgical management was not associated with prolonged survival (p = 0.134).
Use of an administrative database did not allow determination of quality of life or relief of obstruction as an outcome, nor could nonsurgical interventions, eg, endoscopic stenting or octreotide, be assessed.
In this population-based study of patients with stage IV colon cancer who had bowel obstruction, overall survival following obstruction was poor irrespective of treatment. Universally poor outcomes suggest that a diagnosis of obstruction in the setting of advanced colon cancer should be considered a preterminal event.
肠阻塞是晚期腹部癌症(尤其是结肠癌)的常见并发症,主要在小的、单机构研究中进行了研究。
我们使用大型基于人群的数据集,探讨了在 IV 期结肠癌患者因肠梗阻住院后,对肠梗阻的手术治疗及其结果。
这是一项回顾性队列研究。
我们在 Surveillance,Epidemiology and End Results-Medicare 数据库中确定了 1004 名年龄在 65 岁或以上的患者,他们在 1991 年 1 月 1 日至 2005 年 12 月 31 日期间被诊断为 IV 期结肠癌,后来因肠梗阻住院。
我们描述了住院期间的结果,并分析了肠梗阻的手术治疗与结果之间的关系。
肠梗阻住院发生在结肠癌诊断后中位数为 7.4 个月,梗阻后中位生存时间约为 2.5 个月。肠梗阻的中位住院时间约为 1 周,住院死亡率为 12.7%。在出院和死亡之间,25%的患者因梗阻至少再次住院一次,平均而言,患者在肠梗阻诊断和死亡之间的住院天数中,有 5 天在院外。梗阻起源于粘连性梗阻的患者生存时间延长了 3 倍。在多变量模型中,与非手术治疗相比,手术治疗与延长生存时间无关(p = 0.134)。
使用行政数据库无法确定生活质量或梗阻缓解作为结果,也无法评估非手术干预,例如内镜支架或奥曲肽。
在这项基于人群的 IV 期结肠癌患者肠梗阻研究中,无论治疗方法如何,梗阻后总体生存情况均较差。普遍较差的结果表明,晚期结肠癌患者诊断为梗阻应视为终末期事件。